These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19131637)

  • 1. Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.
    Tsai MY; Li N; Sharrett AR; Shea S; Jacobs DR; Tracy R; Arnett D; Arends V; Post W
    Clin Chem; 2009 Mar; 55(3):481-8. PubMed ID: 19131637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of ATP binding cassette transporter A1 R219K and cholesteryl ester transfer protein TaqIB genotypes on HDL-C levels in overweight/obese and non-obese Chinese subjects.
    Huang Y; Wu Y; Liu R; Fan P; Zhang J; Wang F; Luo X; Liu Y; Liu B; Bai H
    Acta Cardiol; 2011 Apr; 66(2):231-7. PubMed ID: 21591583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.
    Tsai MY; Johnson C; Kao WH; Sharrett AR; Arends VL; Kronmal R; Jenny NS; Jacobs DR; Arnett D; O'Leary D; Post W
    Atherosclerosis; 2008 Oct; 200(2):359-67. PubMed ID: 18243217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteryl ester transfer protein and ATP-binding cassette transporter A1 genotype alter the atorvastatin and simvastatin efficacy: time for genotype-guided therapy?
    Kolovou G; Kolovou V; Mihas C; Giannakopoulou V; Vasiliadis I; Boussoula E; Kollia A; Boutsikou M; Katsiki N; Mavrogeni S
    Angiology; 2013 May; 64(4):266-72. PubMed ID: 22584245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.
    Xiao Z; Wang J; Chen W; Wang P; Zeng H; Chen W
    Lipids Health Dis; 2012 Nov; 11():163. PubMed ID: 23181436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fenofibrate therapy and ABCA1 polymorphisms on high-density lipoprotein subclasses in the Genetics of Lipid Lowering Drugs and Diet Network.
    Tsai MY; Ordovas JM; Li N; Straka RJ; Hanson NQ; Arends VL; Arnett D
    Mol Genet Metab; 2010 Jun; 100(2):118-22. PubMed ID: 20346718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women.
    Lamon-Fava S; Asztalos BF; Howard TD; Reboussin DM; Horvath KV; Schaefer EJ; Herrington DM
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):169-75. PubMed ID: 19489872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.
    Tchoua U; D'Souza W; Mukhamedova N; Blum D; Niesor E; Mizrahi J; Maugeais C; Sviridov D
    Cardiovasc Res; 2008 Mar; 77(4):732-9. PubMed ID: 18056760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population.
    Padmaja N; Ravindra Kumar M; Soya SS; Adithan C
    Clin Chim Acta; 2007 Jan; 375(1-2):140-6. PubMed ID: 16890925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Geographical characteristics of single nucleotide polymorphism of candidate genes associated with coronary artery disease in Chinese Han population].
    Wang SH; Cui HB; Wang DQ; Chen XM; Zhang HK; Cui CC; Chen XY; Liu XH; Zhang Z; Bai F; Jb M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):24-9. PubMed ID: 19099922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.
    Abd El-Aziz TA; Mohamed RH; Hagrass HA
    J Clin Lipidol; 2014; 8(4):381-9. PubMed ID: 25110219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.
    Whiting BM; Anderson JL; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2005 Aug; 150(2):243-50. PubMed ID: 16086925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism.
    Karuna R; Holleboom AG; Motazacker MM; Kuivenhoven JA; Frikke-Schmidt R; Tybjaerg-Hansen A; Georgopoulos S; van Eck M; van Berkel TJ; von Eckardstein A; Rentsch KM
    Atherosclerosis; 2011 Feb; 214(2):448-55. PubMed ID: 21130455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four polymorphisms of cholesteryl ester transfer protein gene and coronary stenosis in a Tunisian population.
    Rejeb J; Omezzine A; Boumaiza I; Rebhi L; Rejeb NB; Nabli N; Abdelaziz AB; Boughzala E; Bouslama A
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):546-53. PubMed ID: 22854712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETP.
    Maugeais C; Perez A; von der Mark E; Magg C; Pflieger P; Niesor EJ
    Biochim Biophys Acta; 2013 Nov; 1831(11):1644-50. PubMed ID: 23872476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
    Ordovas JM; Cupples LA; Corella D; Otvos JD; Osgood D; Martinez A; Lahoz C; Coltell O; Wilson PW; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1323-9. PubMed ID: 10807749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.